Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2‐Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

BACKGROUND: The observational study HerMES collected primary data on effectiveness and safety of trastuzumab in patients with human epidermal growth receptor 2 (HER2)‐positive cancer of the stomach or gastroesophageal junction (GEJ) in routine clinical practice, exploring the treatment with trastuzu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Al‐Batran, Salah‐Eddin, Moorahrend, Enno, Maintz, Christoph, Goetze, Thorsten O., Hempel, Dirk, Thuss‐Patience, Peter, Gaillard, Vincent E., Hegewisch‐Becker, Susanna
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
Gastrointestinal Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7418356/
https://ncbi.nlm.nih.gov/pubmed/32311799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0109
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars